Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hirokazu Nagayama"'
Autor:
Nobuyuki Hirama, Masaki Yamamoto, Satoshi Nagaoka, Wataru Segawa, Chihiro Sugimoto, Hirokazu Nagayama, Shuntaro Hiro, Yukihito Kajita, Chihiro Maeda, Sousuke Kubo, Kenichi Seki, Yoshinori Nagahara, Shuhei Teranishi, Ken Tashiro, Yu Hara, Nobuaki Kobayashi, Shigenobu Watanabe, Makoto Kudo, Takeshi Kaneko
Publikováno v:
Thoracic Cancer, Vol 14, Iss 25, Pp 2601-2607 (2023)
Abstract Background Based on the results of the PACIFIC trial, maintenance with durvalumab has emerged as the standard treatment following concurrent chemoradiotherapy in patients with unresectable locally advanced non‐small cell lung carcinoma (NS
Externí odkaz:
https://doaj.org/article/9ea55ed2cec44c0b9c3c0f13da150dab
Autor:
Shuntaro Hiro, Shuhei Teranishi, Tomoe Sawazumi, Satoshi Nagaoka, Chihiro Sugimoto, Hirokazu Nagayama, Wataru Segawa, Yukihito Kajita, Chihiro Maeda, Sousuke Kubo, Kenichi Seki, Ken Tashiro, Nobuaki Kobayashi, Masaki Yamamoto, Makoto Kudo, Takeshi Kaneko
Publikováno v:
Thoracic Cancer, Vol 14, Iss 14, Pp 1311-1315 (2023)
Abstract Thymic neuroendocrine tumors associated with multiple endocrine neoplasia are only defined as carcinoid and are not associated with large‐cell neuroendocrine carcinoma (LCNEC). We report the case of a multiple endocrine neoplasia type 1 pa
Externí odkaz:
https://doaj.org/article/5e9b65466d66490bbac42a94b16f75b7
Autor:
Chihiro Sugimoto, Shuhei Teranishi, Tomoe Sawazumi, Satoshi Nagaoka, Hirokazu Nagayama, Wataru Segawa, Shuntaro Hiro, Yukihito Kajita, Chihiro Maeda, Sousuke Kubo, Kenichi Seki, Ken Tashiro, Nobuaki Kobayashi, Masaki Yamamoto, Makoto Kudo, Takeshi Kaneko
Publikováno v:
Thoracic Cancer, Vol 14, Iss 13, Pp 1212-1216 (2023)
Abstract Primary tracheal small‐cell carcinoma is rare, and is often treated using small‐cell lung cancer guidelines given that no standard treatment has been established for it. We report a patient in whom nodules appeared in the trachea and lef
Externí odkaz:
https://doaj.org/article/ac9ee676ec514e498f4091a1e8e47340
Autor:
Shuhei Teranishi, Chihiro Sugimoto, Satoshi Nagaoka, Hirokazu Nagayama, Wataru Segawa, Atsushi Miyasaka, Shuntaro Hiro, Yukihito Kajita, Chihiro Maeda, Nobuaki Kobayashi, Masaki Yamamoto, Makoto Kudo, Takeshi Kaneko
Publikováno v:
Thoracic Cancer, Vol 13, Iss 19, Pp 2741-2750 (2022)
Abstract Background Clinically measurable factors affecting the progression‐free survival (PFS) of patients receiving osimertinib as first‐line therapy for epidermal growth factor receptor (EGFR) mutation‐positive advanced non‐small cell lung
Externí odkaz:
https://doaj.org/article/d0c6467a156b4524a624f7319ffd8f05
Autor:
Shuhei Teranishi, Chihiro Sugimoto, Satoshi Nagaoka, Hirokazu Nagayama, Wataru Segawa, Atsushi Miyasaka, Shuntaro Hiro, Yukihito Kajita, Chihiro Maeda, Nobuaki Kobayashi, Masaki Yamamoto, Makoto Kudo, Takeshi Kaneko
Publikováno v:
Thoracic Cancer. 13:2741-2750
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1e15486843ae1df129c432485e747f8
https://doi.org/10.1111/1759-7714.14608
https://doi.org/10.1111/1759-7714.14608